Author:
Improta Luca,Valeri Sergio,Alloni Rossana,Pagnoni Chiara,Mallozzi Santa Maria Francesco,Brunetti Beniamino,Greco Carlo,Aprile Irene,Maselli Mirella,Vincenzi Bruno,Gronchi Alessandro
Abstract
Abstract
Background
Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue tumor that typically affects the lower limbs of men between the ages of 50 and 60. EMC of the shoulder is rare with a high risk of local recurrence and distant metastasis. A planned surgical excision in sarcoma referral centers (SRCs) is mandatory to obtain the best outcome. The role of chemotherapy (CHT) and Radiotherapy (RT) on soft tissue chondrosarcoma is still controversial.
Case presentation
A 47-year-old man presented to our referral center with a history of EMC in the right shoulder excised with microscopic positive surgical margins in a non-referral center. Staging imaging exams did not reveal distant metastasis or residual disease, but during follow-up a local recurrence was detected. After a multidisciplinary discussion, preoperative radiotherapy was administered with a total dose of 50 Gy, and then the patient underwent wide surgical excision. Histological examination was negative for viable tumor cells. No relapse occurred in a 24-months post-operative follow up.
Conclusions
The case here described suggests the importance of patient’s management in SRCs. A planned combined treatments with both surgery and RT seems to be the best choice to improve local control. RT seems to be promising within this specific histotype. Further studies are needed to confirm if the observed efficacy of combined treatments reflects in a consistent survival benefit for EMC patients.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Board,WHO Classification of Tumours Editorial. Soft Tissue and Bone Tumours. International Agency for Research on Cancer; 2020.
2. Saleh G, Evans HL, Ro JY, Ayala AG. Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of ten patients with long-term follow-up. Cancer. 1992;70(12):2827–30.
3. Zaki M, Laszewski P, Robinette N, Saleh H, Raza N, Sukari A, et al. Unresectable extraskeletal myxoid chondrosarcoma of the neck: early tumor response to chemoradiotherapy. Cureus. 2015;7(12):e432.
4. Smith MT, Farinacci CJ, Carpenter HA, Bannayan GA. Extraskeletal myxoid chondrosarcoma: a clinicopathological study. Cancer. 1976;37(2):821–7.
5. Drilon AD, Popat S, Bhuchar G, D’Adamo DR, Keohan ML, Fisher C, et al. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer. 2008;113(12):3364–71.